<DOC>
	<DOC>NCT01273376</DOC>
	<brief_summary>The purpose of this study is to determine whether RX-10100 are effective in the treatment of Major Depressive Disorder (MDD).</brief_summary>
	<brief_title>Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<criteria>â€¢ Moderate to severe MDD as determined by the DSMIVTR Axis 1 Disorders and by the Montgomery Asberg Depression Rating Scale (MADRS). Women who are pregnant, women who will be breastfeeding during the study, and women with childbearing potential who are not willing to practice a reliable method of birth control Depressive episode duration of less than 1 month Lifetime history of any psychotic disorders Anxiety disorders Significant suicidality Clinically significant medical conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>MDD</keyword>
	<keyword>Depression</keyword>
	<keyword>Major Depression</keyword>
</DOC>